SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023883
Filing Date
2022-11-09
Accepted
2022-11-09 16:18:37
Documents
60
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imgo-20220930.htm   iXBRL 10-Q 3197027
2 EX-31.1 imgo-ex31_1.htm EX-31.1 34415
3 EX-31.2 imgo-ex31_2.htm EX-31.2 34219
4 EX-32.1 imgo-ex32_1.htm EX-32.1 22816
5 GRAPHIC img194249669_0.jpg GRAPHIC 119101
  Complete submission text file 0000950170-22-023883.txt   8720701

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imgo-20220930_pre.xml EX-101.PRE 243056
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imgo-20220930_lab.xml EX-101.LAB 326192
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imgo-20220930_def.xml EX-101.DEF 162258
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imgo-20220930_cal.xml EX-101.CAL 33404
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imgo-20220930.xsd EX-101.SCH 35851
54 EXTRACTED XBRL INSTANCE DOCUMENT imgo-20220930_htm.xml XML 1386742
Mailing Address 303 TWIN DOLPHIN DRIVE 6TH FLOOR REDWOOD CITY CA 94065
Business Address 303 TWIN DOLPHIN DRIVE 6TH FLOOR REDWOOD CITY CA 94065 (415) 529-5055
Imago BioSciences, Inc. (Filer) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40604 | Film No.: 221372899
SIC: 2834 Pharmaceutical Preparations